tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Helius Medical Technologies Raises $500M for Solana Strategy

Story Highlights
  • Helius Medical Technologies raised over $500 million to implement a SOL treasury strategy.
  • The company plans to acquire SOL and establish Solana treasury operations for yield-generating opportunities.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Helius Medical Technologies Raises $500M for Solana Strategy

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Helius Medical Technologies ( (HSDT) ) has provided an announcement.

On September 15, 2025, Helius Medical Technologies announced the signing of securities purchase agreements with accredited investors, raising over $500 million in a private equity offering to implement a SOL treasury strategy. The company plans to use the proceeds to acquire SOL, the native cryptocurrency of the Solana blockchain, and establish its Solana treasury operations, aiming to leverage Solana’s architecture for yield-generating opportunities in decentralized finance and broader on-chain activity. This strategic move positions Helius to significantly enhance its presence in the crypto technology sector, with potential implications for increased institutional and retail access to the Solana ecosystem.

The most recent analyst rating on (HSDT) stock is a Sell with a $7.00 price target. To see the full list of analyst forecasts on Helius Medical Technologies stock, see the HSDT Stock Forecast page.

Spark’s Take on HSDT Stock

According to Spark, TipRanks’ AI Analyst, HSDT is a Underperform.

Helius Medical Technologies faces significant financial challenges, with declining revenue and ongoing losses being the most impactful factors. The technical analysis indicates a bearish trend, and the valuation metrics are unattractive due to negative earnings. The absence of earnings call data and corporate events further limits the potential for a positive outlook.

To see Spark’s full report on HSDT stock, click here.

More about Helius Medical Technologies

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms.

Average Trading Volume: 401,505

Technical Sentiment Signal: Strong Sell

Current Market Cap: $8.14M

Learn more about HSDT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1